Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172
View on NSE | View on BSE

INR

533.00

-11.5 (-2.11%)

BSENSE

May 06

BSE+NSE Vol: 1.98 lacs

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "533.00",
    "chg": -11.5,
    "chgp": "-2.11%",
    "dir": -1,
    "prev_price": "544.50",
    "mcapval": "12,964.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "India SENSEX",
    "isin": "INE065X01017",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "1.98 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3977183",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndegeneLtd_mojoScore_3977183.png",
        "date": "2026-05-06 08:35:56",
        "description": "Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced shift in its overall outlook. This change is driven by a complex interplay of factors across quality, valuation, financial trends, and technical indicators, signalling cautious optimism amid mixed performance metrics."
      },
      {
        "title": "Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-amid-mixed-market-signals-3975064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndegeneLtd_technicaldot_3975064.png",
        "date": "2026-05-05 08:08:36",
        "description": "Indegene Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent price surge of 6.94% to ₹534.20, coupled with mixed technical readings, suggests cautious optimism amid ongoing volatility in the healthcare services sector."
      },
      {
        "title": "Indegene Ltd Surges 7.28% to Day's High of Rs 533.8 — Outperforms Healthcare Sector by 7.59 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-hits-intraday-high-with-728-surge-on-4-may-2026-3974242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndegeneLtd_priceRelatedfactors_3974242.png",
        "date": "2026-05-04 15:31:05",
        "description": "The Sensex advanced 0.52% on 4 May 2026, yet Indegene Ltd outpaced the broader market with a 7.28% gain, touching an intraday high of Rs 533.8. This 7.59-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Indegene Ltd Gains 1.73%: Margin Pressures and Record Sales Shape Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-gains-173-margin-pressures-and-record-sales-shape-weekly-moves-3971380",
        "imagepath": "",
        "date": "2026-05-02 10:01:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 27:</strong> Stock opens strong at Rs.497.65, up 1.34%</p>\n                    <p><strong>Apr 28:</strong> Continued gains to Rs.499.75 despite Sensex dip</p>\n                    <p><strong>Apr 29:</strong> Profit-taking leads to 0.87% decline to Rs.495.40</p>\n                    <p><strong>Apr 30:</strong> Quarterly results released; stock rebounds to Rs.499.55</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.491.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.499.55</div><d..."
      },
      {
        "title": "Are Indegene Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-ltd-latest-results-good-or-bad-3970757",
        "imagepath": "",
        "date": "2026-04-30 19:17:54",
        "description": "Indegene Ltd's latest financial results for Q4 FY26 present a complex picture characterized by strong revenue growth juxtaposed with significant profitability challenges. The company reported a revenue of ₹1,003.40 crores, marking a year-on-year growth of 32.80% and a sequential increase of 6.51%. This achievement reflects robust demand and operational momentum, as it is the first time Indegene has surpassed the ₹1,000 crore mark in a single quarter.\n\nHowever, the profitability metrics reveal a stark decline. The net profit for the quarter stood at ₹79.70 crores, which represents a year-on-year decrease of 32.23% and a sequential drop of 22.55%. The profit after tax (PAT) margin contracted sharply to 7.94%, down from 15.56% in the same quarter last year, indicating significant challenges in converting revenue growth into profit. Additionally, the operating margin, excluding other income, fell to 16.30% from..."
      },
      {
        "title": "Indegene Ltd Reports Flat Quarterly Financial Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-reports-flat-quarterly-financial-performance-amid-margin-pressures-3970178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_fintrenddot_3970178.png",
        "date": "2026-04-30 11:00:08",
        "description": "Indegene Ltd, a healthcare services small-cap, posted a mixed set of results for the quarter ended March 2026, with record net sales and PBDIT overshadowed by a notable decline in net profit and earnings per share. The company’s financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade from Hold to Sell as investors weigh the implications of margin pressures and subdued bottom-line growth."
      },
      {
        "title": "Indegene Q4 FY26: Profit Plunges 32% Despite Record Revenue as Margins Compress",
        "link": "https://www.marketsmojo.com/news/result-analysis/indegene-q4-fy26-profit-plunges-32-despite-record-revenue-as-margins-compress-3970250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/Indegene_quaterlyResult_3970250.png",
        "date": "2026-04-30 09:49:01",
        "description": "Indegene Limited, a healthcare services provider with a market capitalisation of ₹12,031.53 crores, reported a concerning performance for Q4 FY26, with net profit declining 32.23% year-on-year to ₹79.70 crores despite achieving record quarterly revenue of ₹1,003.40 crores. The stock, trading at ₹499.45, has struggled over the past year, declining 9.12% whilst the broader market fell 4.84%, reflecting investor concerns about deteriorating profitability metrics."
      },
      {
        "title": "Indegene Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-by-marketsmojo-3962086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_mojoScore_3962086.png",
        "date": "2026-04-25 10:10:36",
        "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Indegene Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-indegene-ltd-3958126",
        "imagepath": "",
        "date": "2026-04-22 23:16:13",
        "description": "Indegene Ltd is scheduled to declare its results on 29 April 2026...."
      }
    ],
    "total": 229,
    "sid": "10039241",
    "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals

2026-05-06 08:35:56

Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced shift in its overall outlook. This change is driven by a complex interplay of factors across quality, valuation, financial trends, and technical indicators, signalling cautious optimism amid mixed performance metrics.

Read full news article

Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-05 08:08:36

Indegene Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. The stock’s recent price surge of 6.94% to ₹534.20, coupled with mixed technical readings, suggests cautious optimism amid ongoing volatility in the healthcare services sector.

Read full news article

Indegene Ltd Surges 7.28% to Day's High of Rs 533.8 — Outperforms Healthcare Sector by 7.59 Percentage Points

2026-05-04 15:31:05

The Sensex advanced 0.52% on 4 May 2026, yet Indegene Ltd outpaced the broader market with a 7.28% gain, touching an intraday high of Rs 533.8. This 7.59-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Indegene Ltd Gains 1.73%: Margin Pressures and Record Sales Shape Weekly Moves

2026-05-02 10:01:34

Key Events This Week

Apr 27: Stock opens strong at Rs.497.65, up 1.34%

Apr 28: Continued gains to Rs.499.75 despite Sensex dip

Apr 29: Profit-taking leads to 0.87% decline to Rs.495.40

Apr 30: Quarterly results released; stock rebounds to Rs.499.55

Read full news article

Are Indegene Ltd latest results good or bad?

2026-04-30 19:17:54

Indegene Ltd's latest financial results for Q4 FY26 present a complex picture characterized by strong revenue growth juxtaposed with significant profitability challenges. The company reported a revenue of ₹1,003.40 crores, marking a year-on-year growth of 32.80% and a sequential increase of 6.51%. This achievement reflects robust demand and operational momentum, as it is the first time Indegene has surpassed the ₹1,000 crore mark in a single quarter. However, the profitability metrics reveal a stark decline. The net profit for the quarter stood at ₹79.70 crores, which represents a year-on-year decrease of 32.23% and a sequential drop of 22.55%. The profit after tax (PAT) margin contracted sharply to 7.94%, down from 15.56% in the same quarter last year, indicating significant challenges in converting revenue growth into profit. Additionally, the operating margin, excluding other income, fell to 16.30% from...

Read full news article

Indegene Ltd Reports Flat Quarterly Financial Performance Amid Margin Pressures

2026-04-30 11:00:08

Indegene Ltd, a healthcare services small-cap, posted a mixed set of results for the quarter ended March 2026, with record net sales and PBDIT overshadowed by a notable decline in net profit and earnings per share. The company’s financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade from Hold to Sell as investors weigh the implications of margin pressures and subdued bottom-line growth.

Read full news article

Indegene Q4 FY26: Profit Plunges 32% Despite Record Revenue as Margins Compress

2026-04-30 09:49:01

Indegene Limited, a healthcare services provider with a market capitalisation of ₹12,031.53 crores, reported a concerning performance for Q4 FY26, with net profit declining 32.23% year-on-year to ₹79.70 crores despite achieving record quarterly revenue of ₹1,003.40 crores. The stock, trading at ₹499.45, has struggled over the past year, declining 9.12% whilst the broader market fell 4.84%, reflecting investor concerns about deteriorating profitability metrics.

Read full news article

Indegene Ltd is Rated Hold by MarketsMOJO

2026-04-25 10:10:36

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into the company’s performance and outlook.